JP2022538868A5 - - Google Patents
Info
- Publication number
- JP2022538868A5 JP2022538868A5 JP2021577297A JP2021577297A JP2022538868A5 JP 2022538868 A5 JP2022538868 A5 JP 2022538868A5 JP 2021577297 A JP2021577297 A JP 2021577297A JP 2021577297 A JP2021577297 A JP 2021577297A JP 2022538868 A5 JP2022538868 A5 JP 2022538868A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- item
- micelle
- cationic carrier
- micelle according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025064597A JP2025106480A (ja) | 2019-06-26 | 2025-04-09 | ミセルナノ粒子及びその使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962867097P | 2019-06-26 | 2019-06-26 | |
| US62/867,097 | 2019-06-26 | ||
| US202063043693P | 2020-06-24 | 2020-06-24 | |
| US63/043,693 | 2020-06-24 | ||
| PCT/IB2020/056093 WO2020261227A1 (en) | 2019-06-26 | 2020-06-26 | Micellar nanoparticles and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025064597A Division JP2025106480A (ja) | 2019-06-26 | 2025-04-09 | ミセルナノ粒子及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022538868A JP2022538868A (ja) | 2022-09-06 |
| JP2022538868A5 true JP2022538868A5 (cg-RX-API-DMAC7.html) | 2023-06-29 |
| JP7665540B2 JP7665540B2 (ja) | 2025-04-21 |
Family
ID=74060198
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021577297A Active JP7665540B2 (ja) | 2019-06-26 | 2020-06-26 | ミセルナノ粒子及びその使用 |
| JP2025064597A Pending JP2025106480A (ja) | 2019-06-26 | 2025-04-09 | ミセルナノ粒子及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025064597A Pending JP2025106480A (ja) | 2019-06-26 | 2025-04-09 | ミセルナノ粒子及びその使用 |
Country Status (14)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10844380B1 (en) | 2019-06-17 | 2020-11-24 | Biorchestra Co., Ltd. | Uses for prevention or treatment of brain diseases using microrna |
| CN114080412B (zh) | 2019-06-28 | 2023-08-25 | 国立大学法人东京大学 | 蛋白质内包高分子胶束 |
| CN115461085A (zh) * | 2020-02-07 | 2022-12-09 | 生物欧赛加有限责任公司 | miRNA-485抑制剂用于治疗tau蛋白病的用途 |
| US11761874B2 (en) * | 2020-05-15 | 2023-09-19 | Saudi Arabian Oil Company | CMC-based method for surfactant concentration determination |
| CN116322648A (zh) * | 2020-10-09 | 2023-06-23 | 国立大学法人 东京大学 | 包封烟酰胺的胶束、以及含有包封烟酰胺的胶束的妊娠高血压综合征治疗用组合物 |
| WO2022144811A1 (en) * | 2020-12-30 | 2022-07-07 | Biorchestra Co., Ltd. | Micellar nanoparticles and uses thereof |
| CN116963722A (zh) * | 2020-12-30 | 2023-10-27 | 生物欧赛加有限责任公司 | 胶束纳米粒子及其用途 |
| US20250313835A1 (en) * | 2022-07-07 | 2025-10-09 | Biorchestra Co., Ltd. | Micellar nanoparticles and uses thereof |
| CN115721608A (zh) * | 2022-11-29 | 2023-03-03 | 陕西科技大学 | 一种靶向温度敏感性聚合物胶束、制备方法及应用 |
| WO2024228119A1 (en) * | 2023-05-01 | 2024-11-07 | Biorchestra Co., Ltd. | Mirna-485 inhibitors |
| WO2024228118A1 (en) * | 2023-05-01 | 2024-11-07 | Biorchestra Co., Ltd. | Mirna-485 inhibitors |
| WO2025149946A1 (en) * | 2024-01-10 | 2025-07-17 | Biorchestra Co., Ltd. | Micellar nanoparticles and uses thereof |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US5219564A (en) * | 1990-07-06 | 1993-06-15 | Enzon, Inc. | Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon |
| CN100523215C (zh) | 2000-12-01 | 2009-08-05 | 马普科技促进协会 | 介导rna干涉的小rna分子 |
| JP2005534718A (ja) * | 2002-06-26 | 2005-11-17 | メディゲーネ オンコロギー ゲゼルシャフト ミット ベシュレンクテル ハフツング | カチオンキャリヤー系において診断化合物および治療化合物を安定化させる新規方法 |
| WO2005013901A2 (en) | 2003-07-31 | 2005-02-17 | Isis Pharmaceuticals, Inc. | Oligomeric compounds and compositions for use in modulation of small non-coding rnas |
| US20050142581A1 (en) | 2003-09-04 | 2005-06-30 | Griffey Richard H. | Microrna as ligands and target molecules |
| CA2556752C (en) | 2004-02-23 | 2016-02-02 | Genentech, Inc. | Heterocyclic self-immolative linkers and conjugates |
| AU2005328382C1 (en) | 2004-07-21 | 2013-01-24 | Alnylam Pharmaceuticals, Inc. | Oligonucleotides comprising a modified or non-natural nucleobase |
| US20080213891A1 (en) | 2004-07-21 | 2008-09-04 | Alnylam Pharmaceuticals, Inc. | RNAi Agents Comprising Universal Nucleobases |
| EP1913011B1 (en) | 2004-08-04 | 2016-11-02 | Alnylam Pharmaceuticals Inc. | Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase |
| US20070213292A1 (en) | 2005-08-10 | 2007-09-13 | The Rockefeller University | Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof |
| AU2006279906B2 (en) | 2005-08-10 | 2012-05-10 | Alnylam Pharmaceuticals, Inc. | Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof |
| ATE494372T1 (de) | 2005-08-29 | 2011-01-15 | Regulus Therapeutics Inc | Verfahren für mir-122a-modulation |
| WO2007027894A2 (en) | 2005-08-29 | 2007-03-08 | Isis Pharmaceuticals, Inc. | Antisense compounds having enhanced anti-microrna activity |
| EP2388328A1 (en) | 2006-01-27 | 2011-11-23 | Isis Pharmaceuticals, Inc. | Oligomeric compounds and compositions for the use in modulation of micrornas |
| EA201100811A1 (ru) | 2006-04-03 | 2012-06-29 | Сантарис Фарма А/С | Фармацевтическая композиция |
| CA3042781C (en) | 2006-04-03 | 2021-10-19 | Roche Innovation Center Copenhagen A/S | Pharmaceutical composition comprising anti-mirna antisense oligonucleotides |
| EP2090665A2 (en) | 2006-10-20 | 2009-08-19 | Exiqon A/S | Novel human microRNAs associated with cancer |
| US20090137504A1 (en) | 2006-12-21 | 2009-05-28 | Soren Morgenthaler Echwald | Microrna target site blocking oligos and uses thereof |
| US8580756B2 (en) | 2007-03-22 | 2013-11-12 | Santaris Pharma A/S | Short oligomer antagonist compounds for the modulation of target mRNA |
| DK2205737T3 (da) | 2007-10-04 | 2013-05-21 | Santaris Pharma As | Mikromirer |
| US20090156459A1 (en) * | 2007-11-16 | 2009-06-18 | Pharmain Corporation | Cationic-Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same |
| US8541435B2 (en) * | 2008-07-11 | 2013-09-24 | Uday Saxena | Niacin compositions for reduction of amyloid beta peptide 42 (abeta 42) production and for treatment of Alzheimer's disease (AD) |
| JP5622254B2 (ja) * | 2009-03-31 | 2014-11-12 | 国立大学法人東京大学 | 二本鎖リボ核酸ポリイオンコンプレックス |
| US9034837B2 (en) | 2009-04-24 | 2015-05-19 | Roche Innovation Center Copenhagen A/S | Pharmaceutical compositions for treatment of HCV patients that are poor-responders to interferon |
| LT2459220T (lt) * | 2009-07-31 | 2020-12-28 | Ascendis Pharma A/S | Biologiškai suyrantys vandenyje netirpūs hidrogeliai polietilenglikolio pagrindu |
| CA2773737C (en) * | 2009-09-09 | 2021-11-16 | Pharmain Corporation | Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same |
| US20120005765A1 (en) * | 2010-07-01 | 2012-01-05 | Saint Louis University | Animal model for parkinson's disease |
| WO2012038851A1 (en) | 2010-09-24 | 2012-03-29 | Pfizer Inc. | Isoxazoline oximes as antiparasitic agents |
| US20140371292A1 (en) * | 2011-08-10 | 2014-12-18 | Ludwig-Maximilians-Universitat Munchen | Method for the controlled intracellular delivery of nucleic acids |
| CA2932123C (en) * | 2013-12-05 | 2022-05-31 | Nian WU | Polymer-carbohydrate conjugates for drug delivery technology |
| CN106456662A (zh) * | 2014-02-24 | 2017-02-22 | 奥利金制药公司 | 口服给药的戊聚糖多硫酸盐的组合物及其使用方法 |
| WO2016086177A2 (en) * | 2014-11-25 | 2016-06-02 | Drexel University | Compositions and methods for hiv quasi-species excision from hiv-1-infected patients |
| DK3378482T5 (da) * | 2015-11-19 | 2024-09-30 | Univ Nagoya City Public Univ Corp | Formulering til administration af antitumorlægemiddel |
| WO2017212007A1 (en) * | 2016-06-09 | 2017-12-14 | Curevac Ag | Cationic carriers for nucleic acid delivery |
| CN110392583B (zh) | 2016-09-15 | 2023-01-03 | 加利福尼亚大学董事会 | 改进的杂化的末端树枝状聚合物 |
| RU2016146594A (ru) * | 2016-11-28 | 2018-05-28 | Общество С Ограниченной Ответственностью "Биофарм-Меморейн" | Средство для лечения деменции различной этиологии |
| RU2019121801A (ru) | 2016-12-14 | 2021-01-15 | Лигандал, Инк. | Композиции и способы для доставки полезной нагрузки в виде нуклеиновой кислоты и/или белка |
| WO2018139759A1 (ko) * | 2017-01-26 | 2018-08-02 | 주식회사 바이오오케스트라 | 마이크로 rna를 이용한 알츠하이머병 진단방법 |
| US11123304B2 (en) | 2017-02-03 | 2021-09-21 | The Brigham And Women's Hospital, Inc. | Nanoparticles having poly(ester amide) polymer cores as drug delivery vehicles |
| CN110156971A (zh) | 2018-02-13 | 2019-08-23 | 上海时莱生物技术有限公司 | 一种两亲性嵌段共聚物及其制备方法和纳米胶束载药系统 |
| WO2019204799A1 (en) | 2018-04-20 | 2019-10-24 | University Of Pittsburgh -Of The Commonwealth System Of Higher Education | Cationic amphiphilic polymers for codelivery of hydrophobic agents and nucleic acids |
| CN111632153B (zh) | 2020-06-23 | 2023-02-24 | 宁夏医科大学 | 一种化学基因药物共载的靶向纳米递药系统及其制备方法 |
| WO2022144812A1 (en) | 2020-12-30 | 2022-07-07 | Biorchestra Co., Ltd. | Micellar nanoparticles and uses thereof |
| WO2022144811A1 (en) | 2020-12-30 | 2022-07-07 | Biorchestra Co., Ltd. | Micellar nanoparticles and uses thereof |
-
2020
- 2020-06-26 MX MX2022000045A patent/MX2022000045A/es unknown
- 2020-06-26 PE PE2021002229A patent/PE20220902A1/es unknown
- 2020-06-26 KR KR1020247009114A patent/KR20240039234A/ko not_active Ceased
- 2020-06-26 JP JP2021577297A patent/JP7665540B2/ja active Active
- 2020-06-26 WO PCT/IB2020/056093 patent/WO2020261227A1/en not_active Ceased
- 2020-06-26 EP EP25172311.0A patent/EP4603589A3/en active Pending
- 2020-06-26 AU AU2020303447A patent/AU2020303447A1/en not_active Abandoned
- 2020-06-26 US US17/622,518 patent/US20220257790A1/en active Pending
- 2020-06-26 DK DK20831649.7T patent/DK3990028T3/da active
- 2020-06-26 CN CN202080057979.XA patent/CN114514038B/zh active Active
- 2020-06-26 BR BR112021026365A patent/BR112021026365A2/pt unknown
- 2020-06-26 CA CA3144333A patent/CA3144333A1/en active Pending
- 2020-06-26 EP EP20831649.7A patent/EP3990028B1/en active Active
- 2020-06-26 KR KR1020227002029A patent/KR102658962B1/ko active Active
-
2021
- 2021-10-15 US US17/502,923 patent/US11839624B2/en active Active
- 2021-12-22 IL IL289258A patent/IL289258A/en unknown
-
2022
- 2022-01-17 CO CONC2022/0000316A patent/CO2022000316A2/es unknown
-
2023
- 2023-11-07 US US18/503,748 patent/US20240173348A1/en not_active Abandoned
-
2025
- 2025-04-09 JP JP2025064597A patent/JP2025106480A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12180477B2 (en) | Dynamic pharmacokinetic-modifying anchors | |
| EP3378482B1 (en) | Antitumor drug delivery formulation | |
| EP2796150B1 (en) | Novel oligonucleotide conjugates and use thereof | |
| JP2025106480A5 (cg-RX-API-DMAC7.html) | ||
| US20230061751A1 (en) | Universal dynamic pharmacokinetic-modifying anchors | |
| EP2892505B1 (en) | Lipid assemblies comprising anionic lysolipids and use thereof | |
| US20220267775A1 (en) | CANCER TREATMENT USING TARGETED siRNA PHARMACEUTICAL FORMULATIONS TO DOWNREGULATE EXPRESSION OF PRDM14 PROTEIN | |
| Sarisozen et al. | Lipid-based siRNA delivery systems: challenges, promises and solutions along the long journey | |
| Xu et al. | Efficient siRNA delivery using PEG-conjugated PAMAM dendrimers targeting vascular endothelial growth factor in a CoCl2-induced neovascularization model in retinal endothelial cells | |
| JP2024503302A5 (cg-RX-API-DMAC7.html) | ||
| JP2017502959A (ja) | 生体内及び体外で核酸類薬物を送達するための新規な糖アルコール類組成物 | |
| JP2024503303A5 (cg-RX-API-DMAC7.html) | ||
| IL316806A (en) | Compositions and methods for treating monogenic neurodevelopmental disorder | |
| CN120641564A (zh) | 用于抑制腺苷酸环化酶9(ac9)的组合物和方法 | |
| JP2023532536A5 (cg-RX-API-DMAC7.html) | ||
| JP2023513188A5 (cg-RX-API-DMAC7.html) | ||
| JP2023513190A5 (cg-RX-API-DMAC7.html) | ||
| WO2024255846A1 (en) | Oligonucleotide formulation | |
| EP4196588A2 (en) | Anti-seed pnas and microrna inhibition | |
| KR20240072931A (ko) | 히스티딘을 포함하는 지질 나노입자 및 그 제조방법 | |
| TW202241460A (zh) | 微胞奈米粒子及其用途 | |
| WO2023215878A2 (en) | Calcium salted spherical nucleic acids | |
| CN118695875A (zh) | 在用于治疗和/或预防疾病的方法中使用的制剂 | |
| JP2023513189A5 (cg-RX-API-DMAC7.html) | ||
| CN111228505B (zh) | 一种蒽醌类药物和核酸复合物纳米递送体系及其制备方法与应用 |